Reduced inflammation: Inflammatory markers often decrease, potentially reducing vascular inflammation that contributes to atherosclerosis
58 References 1
Rosenstock, J., et al., Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
We wanted to make sure employers have the choice. Also on Thursday, the executive director of the Group Insurance Commission, the Massachusetts agency that provides health insurance for 460,000 state employees, said its been running a $20 million monthly deficit, partly due to rising claims from members taking GLP-1s to treat obesity
Related Reading Why Am I Not Losing Weight on Semaglutide How Long Does It Take for Glp-1 to Work GLP-1 vs Wegovy Who Can Prescribe GLP-1 Semaglutide vs Metformin for Weight Loss Is GLP-1 the Same as Ozempic
Keep a bottle with you and drink from it constantly rather than trying to catch up at meals